A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 9, 2018

Primary Completion Date

November 7, 2018

Study Completion Date

November 7, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-925

TAK-925 intravenous infusion.

DRUG

TAK-925 Placebo

TAK-925 placebo-matching given as saline intravenous infusion.

DRUG

Modafinil

Modafinil tablets.

DRUG

Modafinil Placebo

Modafinil placebo-matching tablet.

Trial Locations (1)

PRA Health Sciences, Salt Lake City